Forecast for Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
Description
The National Center for Advancing Translational Sciences, along with other NIH Institutes, plans to announce a funding opportunity for research aimed at improving clinical trial readiness in rare diseases. The goal is to support projects that help move potential treatments or diagnostics toward clinical trials more efficiently and successfully. This may involve developing biomarkers, clinical outcome assessments, or understanding a rare disease's progression to guide trial design. While appl…
The National Center for Advancing Translational Sciences, with other NIH Institutes and Centers (ICs), intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on projects that address critical needs for clinical trial readiness in rare diseases. The i…
Source
Grant ID
FOR-TR-27-001
Agency
Department of Health and Human Services
Subcategory/Subagency
National Institutes of Health
Eligibility
The following categories of applicants are invited to apply:
- State governments
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- For profit organizations other than small businesses
- Independent school districts
- Native American tribal governments (Federally recognized)
- County governments
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Small businesses
- Public and State controlled institutions of higher education
Links
Similar opportunities
- Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
- Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
Department of Health and Human Services
- Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Department of Health and Human Services
- Efficient and Innovative Natural History Studies for Rare Diseases
Department of Health and Human Services